Literature DB >> 32486074

Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson's Disease in Germany.

Hannah M Zipprich1,2, Ulrike Teschner1, Otto W Witte1,2, Aline Schönenberg1, Tino Prell1,2.   

Abstract

Background: Adherence to measures that have been adopted during the COVID-19 pandemic is crucial to control the spread of the coronavirus.
Methods: Semi-structured telephone interviews were performed with 99 patients with Parkinson's disease (PD) and 21 controls to explore knowledge, attitudes, practices, and burden in order to elucidate nonadherence to preventive measures.
Results: The majority of patients understood the preventive measures and felt sufficiently informed. Analysis of qualitative answers, however, showed that about 30% of patients had an insufficient level of knowledge, which was not associated with educational level, cognitive disorders, or depression. Changes in behaviour were reported by 73 patients (99% performed at least one specific preventive behavior, and 86.9% have reduced social contacts and stayed home). A closer analysis of qualitative answers showed that 27.3% of patients continued to meet relatives face-to-face almost daily. Anxiety and worries about the current situation were reported by 58.6% of patients; 31.3% complained about a decrease in their mobility since the beginning of the restrictions, mainly because of worsening of PD and because regular therapies (e.g., physiotherapy) were canceled. Conclusions: About 30% of PD patients are nonadherent to preventive measures. Use of simple dichotomous questions overestimates adherence to preventive measures in patients with PD.

Entities:  

Keywords:  COVID-19; attitudes; knowledge; pandemic; practices

Year:  2020        PMID: 32486074     DOI: 10.3390/jcm9061643

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  25 in total

1.  Spotlight on non-motor symptoms and Covid-19.

Authors:  Silvia Rota; Iro Boura; Yi-Min Wan; Claudia Lazcano-Ocampo; Mayela Rodriguez-Violante; Angelo Antonini; Kallol Ray Chaudhuri
Journal:  Int Rev Neurobiol       Date:  2022-07-09       Impact factor: 4.280

2.  Parkinson's disease and Covid-19: The effect and use of telemedicine.

Authors:  Aleksandra M Podlewska; Daniel J van Wamelen
Journal:  Int Rev Neurobiol       Date:  2022-07-14       Impact factor: 4.280

3.  Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.

Authors:  Conor Fearon; Alfonso Fasano
Journal:  Int Rev Neurobiol       Date:  2022-04-20       Impact factor: 4.280

4.  A Self-Reported Clinical Tool Predicts Falls in People with Parkinson's Disease.

Authors:  Lorena Rosa S Almeida; Maria Elisa Pimentel Piemonte; Helen M Cavalcanti; Colleen G Canning; Serene S Paul
Journal:  Mov Disord Clin Pract       Date:  2021-03-11

5.  Impact of first COVID-19 lockdown on paediatric and adult haemophilia patients treated in a French Haemophilia Comprehensive Care Centre.

Authors:  Fabienne Volot; Agnes Soudry-Faure; Anamaria Callegarin; Eléa Ksiazek; Stephanie Delienne; Yves Cottin; Marc Maynadié; Mathieu Boulin
Journal:  Haemophilia       Date:  2022-03-03       Impact factor: 4.263

6.  COVID-19 Pandemic Preparedness and Response of Chronic Disease Patients in Public Health Facilities.

Authors:  Tinsae Abeya Geleta; Berhanu Senbeta Deriba; Rebik Shukure Beyane; Ahmed Mohammed; Tadesse Birhanu; Kemal Jemal
Journal:  Int J Gen Med       Date:  2020-11-05

7.  A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study.

Authors:  Margherita Fabbri; Clémence Leung; Guillaume Baille; Matthieu Béreau; Christine Brefel Courbon; Giovanni Castelnovo; Nicolas Carriere; Philippe Damier; Luc Defebvre; Anne Doe de Maindreville; Frederique Fluchere; Marie Fuzzatti; David Grabli; David Maltete; Vanessa Rousseau; Agnès Sommet A; Claire Thalamas; Claire Thiriez; Olivier Rascol; Fabienne Ory-Magne
Journal:  Parkinsonism Relat Disord       Date:  2021-07-13       Impact factor: 4.402

8.  The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson's Disease.

Authors:  Anouk van der Heide; Marjan J Meinders; Bastiaan R Bloem; Rick C Helmich
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  COVID-19 in Parkinson's disease: what holds the key?

Authors:  R Sainz-Amo; B Baena-Álvarez; I Pareés; G Sánchez-Díez; P Pérez-Torre; J L López-Sendón; S Fanjul-Arbos; E Monreal; I Corral-Corral; N García-Barragán; J C Martínez-Castrillo; A Fasano; A Alonso-Cánovas
Journal:  J Neurol       Date:  2020-10-24       Impact factor: 4.849

10.  Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients.

Authors:  Diego Santos-García; Mila Oreiro; Patricia Pérez; Gemma Fanjul; Jose Manuel Paz González; María José Feal Painceiras; Carlos Cores Bartolomé; Lorena Valdés Aymerich; Carlos García Sancho; Maria Del Mar Castellanos Rodrigo
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 9.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.